DUXAP8 and cancer: Based on the following factors, subgroup analysis was done to evaluate the relationship between DUXAP8 expression levels and OS: follow-up time (<60 or ≥60 months) (Figure 2A), the system of cancer (digestive system, urogenital system, respiratory system, hematologic system or other) (Figure 2B), sample size (<100 or ≥100 tissues) (Figure 2C), sample source (clinical samples or database) (Figure 2D), the quality of included literature (NOS scores) (Figure 2E), and type of cancer (Figure 2F).